Literature DB >> 23280063

Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.

Gina J Walter1, Hayley G Evans, Bina Menon, Nicola J Gullick, Bruce W Kirkham, Andrew P Cope, Frédéric Geissmann, Leonie S Taams.   

Abstract

OBJECTIVE: Despite the high frequency of CD4+ T cells with a regulatory phenotype (CD25+CD127(low) FoxP3+) in the joints of patients with rheumatoid arthritis (RA), inflammation persists. One possible explanation is that human Treg cells are converted into proinflammatory interleukin-17 (IL-17)-producing cells by inflammatory mediators and thereby lose their suppressive function. The aim of this study was to investigate whether activated monocytes, which are potent producers of inflammatory cytokines and are abundantly present in the rheumatic joint, induce proinflammatory cytokine expression in human Treg cells and impair their regulatory function.
METHODS: The presence and phenotype of CD4+CD45RO+CD25+CD127(low) T cells (memory Treg cells) and CD14+ monocytes in the peripheral blood (PB) and synovial fluid (SF) of patients with RA were investigated by flow cytometry. Memory Treg cells obtained from healthy control subjects underwent fluorescence-activated cell sorting and then were cocultured with autologous activated monocytes and stimulated with anti-CD3 monoclonal antibodies. Intracellular cytokine expression, phenotype, and function of cells were determined by flow cytometry, enzyme-linked immunosorbent assay, and proliferation assays.
RESULTS: In patients with RA, the frequencies of CD4+CD45RO+CD25+CD127(low) Treg cells and activated CD14+ monocytes were higher in SF compared with PB. In vitro-activated monocytes induced an increase in the percentage of IL-17-positive, interferon-γ (IFNγ)-positive, and tumor necrosis factor α (TNFα)-positive Treg cells as well as IL-10-positive Treg cells. The observed increase in IL-17-positive and IFNγ-positive Treg cells was driven by monocyte-derived IL-1β, IL-6, and TNFα and was mediated by both CD14+CD16- and CD14+CD16+ monocyte subsets. Despite enhanced cytokine expression, cells maintained their CD25+FoxP3+CD39+ Treg cell phenotype and showed an enhanced capacity to suppress T cell proliferation and IL-17 production.
CONCLUSION: Treg cells exposed to a proinflammatory environment show increased cytokine expression as well as enhanced suppressive activity.
Copyright © 2013 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23280063      PMCID: PMC3947722          DOI: 10.1002/art.37832

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  50 in total

1.  Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta.

Authors:  Lili Xu; Atsushi Kitani; Ivan Fuss; Warren Strober
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

2.  Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis.

Authors:  Jocea M R van Amelsfort; Joel A G van Roon; Madelon Noordegraaf; Kim M G Jacobs; Johannes W J Bijlsma; Floris P J G Lafeber; Leonie S Taams
Journal:  Arthritis Rheum       Date:  2007-03

3.  The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.

Authors:  Anya Schneider; Mary Rieck; Srinath Sanda; Catherine Pihoker; Carla Greenbaum; Jane H Buckner
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

4.  Identification of IL-17-producing FOXP3+ regulatory T cells in humans.

Authors:  Kui Shin Voo; Yui-Hsi Wang; Fabio R Santori; Cesar Boggiano; Yi-Hong Wang; Kazuhiko Arima; Laura Bover; Shino Hanabuchi; Jahan Khalili; Ekaterina Marinova; Biao Zheng; Dan R Littman; Yong-Jun Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-09       Impact factor: 11.205

5.  Molecular antagonism and plasticity of regulatory and inflammatory T cell programs.

Authors:  Xuexian O Yang; Roza Nurieva; Gustavo J Martinez; Hong Soon Kang; Yeonseok Chung; Bhanu P Pappu; Bhavin Shah; Seon Hee Chang; Kimberly S Schluns; Stephanie S Watowich; Xin-Hua Feng; Anton M Jetten; Chen Dong
Journal:  Immunity       Date:  2008-06-26       Impact factor: 31.745

6.  Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells.

Authors:  Hans J P M Koenen; Ruben L Smeets; Paul M Vink; Esther van Rijssen; Annemieke M H Boots; Irma Joosten
Journal:  Blood       Date:  2008-07-10       Impact factor: 22.113

7.  Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes.

Authors:  Hayley G Evans; Tesha Suddason; Ian Jackson; Leonie S Taams; Graham M Lord
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

8.  Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses.

Authors:  Ye Zheng; Ashutosh Chaudhry; Arnold Kas; Paul deRoos; Jeong M Kim; Tin-Tin Chu; Lynn Corcoran; Piper Treuting; Ulf Klein; Alexander Y Rudensky
Journal:  Nature       Date:  2009-02-01       Impact factor: 49.962

9.  Phenotypic and functional features of human Th17 cells.

Authors:  Francesco Annunziato; Lorenzo Cosmi; Veronica Santarlasci; Laura Maggi; Francesco Liotta; Benedetta Mazzinghi; Eliana Parente; Lucia Filì; Simona Ferri; Francesca Frosali; Francesco Giudici; Paola Romagnani; Paola Parronchi; Francesco Tonelli; Enrico Maggi; Sergio Romagnani
Journal:  J Exp Med       Date:  2007-07-16       Impact factor: 14.307

10.  Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor.

Authors:  Lorenzo Cosmi; Raffaele De Palma; Veronica Santarlasci; Laura Maggi; Manuela Capone; Francesca Frosali; Gabriella Rodolico; Valentina Querci; Gianfranco Abbate; Roberta Angeli; Liberato Berrino; Massimiliano Fambrini; Marzia Caproni; Francesco Tonelli; Elena Lazzeri; Paola Parronchi; Francesco Liotta; Enrico Maggi; Sergio Romagnani; Francesco Annunziato
Journal:  J Exp Med       Date:  2008-07-28       Impact factor: 14.307

View more
  32 in total

1.  [T helper cell differentiation and plasticity].

Authors:  S Sitte; D Voehringer
Journal:  Z Rheumatol       Date:  2013-08       Impact factor: 1.372

Review 2.  TREG-cell therapies for autoimmune rheumatic diseases.

Authors:  Makoto Miyara; Yoshinaga Ito; Shimon Sakaguchi
Journal:  Nat Rev Rheumatol       Date:  2014-07-01       Impact factor: 20.543

Review 3.  Treg cells in autoimmunity: from identification to Treg-based therapies.

Authors:  Lisa Göschl; Clemens Scheinecker; Michael Bonelli
Journal:  Semin Immunopathol       Date:  2019-04-05       Impact factor: 9.623

4.  Serum amyloid A induces mitogenic signals in regulatory T cells via monocyte activation.

Authors:  Khoa D Nguyen; Claudia Macaubas; Phi Truong; Nan Wang; Tieying Hou; Taejin Yoon; Elizabeth D Mellins
Journal:  Mol Immunol       Date:  2014-03-13       Impact factor: 4.407

5.  Role of myeloid-derived suppressor cells in autoimmune disease.

Authors:  Kristen R Crook; Peng Liu
Journal:  World J Immunol       Date:  2014-03-27

Review 6.  Treg cells in rheumatoid arthritis: an update.

Authors:  Faye A H Cooles; John D Isaacs; Amy E Anderson
Journal:  Curr Rheumatol Rep       Date:  2013-09       Impact factor: 4.592

Review 7.  Functional Defects of Treg Cells: New Targets in Rheumatic Diseases, Including Ankylosing Spondylitis.

Authors:  Jinlin Miao; Ping Zhu
Journal:  Curr Rheumatol Rep       Date:  2018-04-16       Impact factor: 4.592

8.  Pseudomonas aeruginosa Infection Impairs NKG2D-Dependent NK Cell Cytotoxicity through Regulatory T-Cell Activation.

Authors:  Mickael Vourc'h; Gaelle David; Benjamin Gaborit; Alexis Broquet; Cedric Jacqueline; Tanguy Chaumette; Jocelyne Caillon; Antoine Roquilly; Christelle Retiere; Karim Asehnoune
Journal:  Infect Immun       Date:  2020-11-16       Impact factor: 3.441

9.  Dedicator of cytokinesis 8-deficient patients have a breakdown in peripheral B-cell tolerance and defective regulatory T cells.

Authors:  Erin Janssen; Henner Morbach; Sumana Ullas; Jason M Bannock; Christopher Massad; Laurence Menard; Isil Barlan; Gerard Lefranc; Helen Su; Majed Dasouki; Waleed Al-Herz; Sevgi Keles; Talal Chatila; Raif S Geha; Eric Meffre
Journal:  J Allergy Clin Immunol       Date:  2014-09-11       Impact factor: 10.793

10.  Preferential Induction of the T Cell Auxiliary Signaling Molecule B7-H3 on Synovial Monocytes in Rheumatoid Arthritis.

Authors:  Bo Ruem Yoon; Yeon-Ho Chung; Su-Jin Yoo; Kenji Kawara; Jinhyun Kim; In Seol Yoo; Chung-Gyu Park; Seong Wook Kang; Won-Woo Lee
Journal:  J Biol Chem       Date:  2015-12-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.